Cargando…

Eribulin Mesylate-related Multifocal Demyelinating Neuropathy with Myokymia in a Breast Cancer Patient

We herein report a 48-year-old woman receiving eribulin mesylate for breast cancer who presented with gait disorder, distal limb paresthesia, and weakness progressing monthly. A nerve conduction study indicated demyelination with multifocal conduction block. Considering the immune-mediated pathology...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsunogae, Marie, Fujiwara, Satoru, Shiomi, Yuma, Kikawa, Yuichiro, Kohara, Nobuo, Kawamoto, Michi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429294/ https://www.ncbi.nlm.nih.gov/pubmed/33678744 http://dx.doi.org/10.2169/internalmedicine.6780-20

Ejemplares similares

High-dose immunoglobulin-dependent chronic demyelinating inflammatory polyneuropathy successfully managed with subcutaneous immunoglobulin using pharmacokinetic analysis
por: Hiya, Satomi, et al.
Publicado: (2022)

Neurological Manifestations and Long-term Sequelae in Hospitalized Patients with COVID-19
por: Ishiyama, Hiroyuki, et al.
Publicado: (2021)

Eribulin mesylate in the treatment of metastatic breast cancer
por: Jain, Sarika, et al.
Publicado: (2012)

A Punctate Magnetic Resonance Imaging Pattern in a Patient with Systemic Lupus Erythematosus Is an Early Sign of Progressive Multifocal Leukoencephalopathy: A Clinicopathological Study
por: Ishii, Junko, et al.
Publicado: (2018)

Post COVID-19 Bilateral Facial Nerve Palsy
por: Inui, Ryoma, et al.
Publicado: (2021)

Efficacy and safety of eribulin mesylate in advanced soft tissue sarcomas
por: Noujaim, Jonathan, et al.
Publicado: (2016)

Eribulin mesylate exerts antitumor effects via CD103
por: Oya, Kazumasa, et al.
Publicado: (2023)

Sustained atypical myokymia of the abductor pollicis brevis with a focal slowing of the median nerve motor axons at the wrist
por: Murase, Nagako, et al.
Publicado: (2020)

Eribulin mesylate as a microtubule inhibitor for treatment of patients with metastatic breast cancer
por: Muñoz-Couselo, Eva, et al.
Publicado: (2011)

Clinical Utility of Eribulin Mesylate in the Treatment of Breast Cancer: A Chinese Perspective
por: Yuan, Peng, et al.
Publicado: (2021)

Multifocal nodular hypertrophy of trigeminal nerve in multifocal acquired demyelinating sensory and motor neuropathy
por: Kuwahara, Motoi, et al.
Publicado: (2019)

Sonographic Multifocal Cranial Nerve Enlargement in Multifocal Acquired Demyelinating Sensory and Motor Neuropathy
por: Oka, Yuwa, et al.
Publicado: (2021)

Eribulin mesylate in patients with refractory cancers: a Phase I study
por: Mukohara, Toru, et al.
Publicado: (2011)

Pharmacokinetics of eribulin mesylate in cancer patients with normal and impaired renal function
por: Tan, Antoinette R., et al.
Publicado: (2015)

COVID-19-Related Multifocal Demyelinating Neuropathy: Causation or Association
por: Elavarasi, Arunmozhimaran, et al.
Publicado: (2021)

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy
por: Vahdat, Linda T., et al.
Publicado: (2013)

Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study
por: Gamucci, Teresa, et al.
Publicado: (2014)

Eribulin Mesylate Targets Human Telomerase Reverse Transcriptase in Ovarian Cancer Cells
por: Yamaguchi, Satoko, et al.
Publicado: (2014)

Eribulin mesylate induces bone mass loss by promoting osteoclastic bone resorption in mice
por: Ishizaka, Takahiro, et al.
Publicado: (2023)

Facial Myokymia Due to a Pontine Inflammatory Demyelinating Disorder Associated with Mixed Connective Tissue Disorder [MCTD]
por: Maramattom, Boby Varkey
Publicado: (2020)

Multiple Sclerosis and Peripheral Multifocal Demyelinating Neuropathies Occurring in a Same Patient
por: Kwon, Joo Young, et al.
Publicado: (2008)

A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate
por: Nieder, Carsten, et al.
Publicado: (2012)

Eribulin mesylate reduces tumor microenvironment abnormality by vascular remodeling in preclinical human breast cancer models
por: Funahashi, Yasuhiro, et al.
Publicado: (2014)

Eribulin Mesylate Combined with Local Treatment for Brain Metastasis from Breast Cancer: Two Case Reports
por: Byun, Kyung-Do, et al.
Publicado: (2016)

Topiramate-Induced Persistent Eyelid Myokymia
por: Khalkhali, Mohammadrasoul
Publicado: (2016)

Continuous facial myokymia in multiple sclerosis
por: Clay, Jordan L., et al.
Publicado: (2020)

Video Presentation of Myokymia in a Snakebite
por: Garg, Aman, et al.
Publicado: (2021)

Clinical Impact of Large Vessel Occlusion Achieved First Pass Effect with Stent Retriever Alone: A Single-Center Retrospective Analysis
por: Tsunogae, Marie, et al.
Publicado: (2021)

Prevalence of chronic inflammatory demyelinating polyneuropathy and multifocal motor neuropathy in two regions of Australia
por: Park, Susanna B., et al.
Publicado: (2022)

Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study
por: Di Cosimo, Serena, et al.
Publicado: (2019)

Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate
por: Papadaki, Maria A., et al.
Publicado: (2022)

Isolated progression of miliary brain metastasis in a patient with stable lung adenocarcinoma successfully treated with whole-brain radiotherapy: A case report
por: Hiya, Satomi, et al.
Publicado: (2021)

Reversible Cerebral Vasoconstriction Syndrome in Early Pregnancy Treated with Endovascular Therapy
por: Fujiwara, Satoru, et al.
Publicado: (2020)

Post-hyperventilation Apnea with Spindle Activity on Electroencephalogram
por: Ueda, Jun, et al.
Publicado: (2018)

Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors
por: Koczywas, M, et al.
Publicado: (2014)

Superior Oblique Myokymia: Some Novel Observations
por: Sathyan, Sanitha, et al.
Publicado: (2017)

Multifocal demyelinating motor neuropathy and hamartoma syndrome associated with a de novo PTEN mutation
por: Bansagi, Boglarka, et al.
Publicado: (2018)

Hemiatrophy of the Tongue with Contralateral Hemiparesis in a Patient with Multifocal Acquired Demyelinating Sensory and Motor Neuropathy
por: Ikenoshita, Susumu, et al.
Publicado: (2017)

Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience
por: Srinivasa, BJ, et al.
Publicado: (2018)

Cost Effectiveness Analysis of Eribulin Mesylate as a Treatment for Metastatic Breast Cancer in Spain: Management in the Later Line of Therapy
por: Tremblay, Gabriel, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lkggudai334udjlksb9ir17g99